.

0 (hodnocen0 x )

EB

ONLINE

Singapore : Springer Singapore Pte. Limited, 2022

1 online resource (479 pages)

ISBN 9789811679452 (electronic bk.)

ISBN 9789811679445

Print version: Al-Shamsi, Humaid O. Cancer in the Arab World Singapore : Springer Singapore Pte. Limited,c2022 ISBN 9789811679445

Intro -- Acknowledgment -- Contents -- About the Editors -- Chapter 1: Introduction -- 1.1 Background -- 1.2 Cancer Profile in the Arab World: An Overview -- 1.3 Cancer Risk Factors -- 1.4 Current Circumstantial Analysis -- 1.5 Oncology Care in the Arab World -- 1.5.1 Role of Cancer Registries -- 1.5.2 Functionality of Oncology Societies in the Arab Region -- 1.6 Cancer Control Framework Recommendations -- 1.7 Cancer in the Arab World Book -- 1.7.1 Book Structure -- 1.8 Closing the Gaps in the Cancer Care System -- 1.9 Concluding Remarks -- References -- Chapter 2: General Oncology Care in Algeria -- 2.1 Algeria Demographics -- 2.2 Cancer Statistics in Algeria -- 2.2.1 Cancer Incidence in Algeria -- 2.3 Oncology Care in Algeria -- 2.3.1 National Cancer Control Plan 2015-2019 -- 2.4 Cancer Risk Factors -- 2.5 Cancer Screening Programs -- 2.5.1 Cervical Cancer -- 2.5.2 Breast Cancer -- 2.5.3 Colorectal Cancer -- 2.5.4 Prostate Cancer -- 2.6 Cancer Prevention Programs -- 2.7 Cancer Diagnosis -- 2.8 Treatment -- 2.8.1 Medical Oncology -- 2.8.2 Radiation Therapy -- 2.8.3 Surgery -- 2.8.4 Pediatric Oncology -- 2.8.5 Survivorship Track -- 2.8.6 Palliative Care Track -- 2.9 Research and Education -- 2.9.1 Clinical Trials and Research -- 2.9.2 Scientific Publications -- 2.9.3 Training and Education -- 2.9.4 Paramedical Training -- 2.10 Cost Effective Cancer Care -- 2.11 Challenges and Advantages -- 2.11.1 Access to Innovative Treatments -- 2.11.2 Cancer Care -- 2.12 The Future of Cancer Care in Algeria -- 2.13 Conclusion -- References -- Chapter 3: General Oncology Care in Bahrain -- 3.1 Bahrain Demographics -- 3.2 Cancer Statistics in Bahrain -- 3.3 Oncology Care in Bahrain -- 3.4 Cancer Risk Factors -- 3.5 Cancer Screening Programs -- 3.6 Cancer Prevention Programs -- 3.7 Cancer Diagnosis -- 3.8 Treatment -- 3.8.1 Medical Oncology.

10.3 Healthcare System in Mauritania -- 10.4 Oncology Care in Mauritania -- 10.5 Cancer Risk Factors -- 10.6 Cancer Screening Programs -- 10.7 Cancer Prevention Programs -- 10.8 Cancer Diagnosis -- 10.9 Treatment -- 10.9.1 Medical Oncology -- 10.9.2 Radiation Therapy -- 10.9.3 Surgery -- 10.9.4 Pediatric Oncology -- 10.9.5 Survivorship Track -- 10.9.6 Palliative Care Track -- 10.10 Research and Education -- 10.11 Cost-Effective Cancer Care -- 10.12 Challenges and Advantages -- 10.13 The Future of Cancer Care in Mauritania -- 10.14 Conclusion -- References -- Chapter 11: General Oncology Care in Morocco -- 11.1 Morocco Demographics -- 11.2 Cancer Statistics in Morocco -- 11.3 Cancer Risk Factors -- 11.3.1 Tobacco -- 11.3.2 Alcohol -- 11.3.3 Obesity -- 11.3.4 Other Risk Factors -- 11.4 Cancer Screening Programs -- 11.5 Cancer Prevention Programs -- 11.6 Cancer Diagnosis -- 11.7 Treatment -- 11.7.1 Medical Oncology -- 11.7.2 Radiation Therapy -- 11.7.3 Surgery -- 11.7.4 Pediatric Oncology -- 11.7.5 Survivorship Track -- 11.7.6 Palliative Care Track -- 11.8 Research and Education -- 11.8.1 Research -- 11.8.2 Education -- 11.9 Cost-Effective Cancer Care -- 11.10 Challenges and Advantages -- 11.11 The Future of Cancer Care in Morocco -- 11.11.1 Quality Improvement -- 11.11.2 Information Systems -- 11.12 Conclusion -- References -- Chapter 12: General Oncology Care in Oman -- 12.1 Oman Demographics -- 12.2 Cancer Statistics in Oman -- 12.3 Healthcare System in Oman -- 12.4 Oncology Care in Oman -- 12.4.1 Access to Cancer Care services -- 12.4.2 Multi-sectoral Efforts to Prevent and Control Cancer -- 12.4.3 National Oncology Center: The Royal Hospital -- 12.4.4 Other Cancer Centers -- 12.4.5 National Cancer Registry -- 12.4.6 Community Obligations -- 12.4.7 The Cancer Care Plan -- 12.5 Cancer Risk Factors -- 12.6 Cancer Screening Programs.

3.8.2 Radiation Therapy -- 3.8.3 Surgery -- 3.8.4 Pediatric Oncology -- 3.8.5 Survivorship Track -- 3.8.6 Palliative Care Track -- 3.9 Research and Education -- 3.9.1 National Tumor Board (NTB) -- 3.10 Cost-Effective Cancer Care -- 3.11 Challenges and Advantages -- 3.12 The Future of Cancer Care in Bahrain -- 3.13 Conclusion -- References -- Chapter 4: General Oncology Care in Egypt -- 4.1 Egypt Demographics -- 4.1.1 Population -- 4.1.2 Regions -- 4.1.3 Economy -- 4.1.4 Government -- 4.1.5 Life Expectancy -- 4.2 Cancer Statistics in Egypt -- 4.3 Oncology Care in Egypt -- 4.3.1 Liver Cancer -- 4.3.2 Breast Cancer -- 4.3.3 Bladder Cancer -- 4.4 Cancer Risk Factors -- 4.4.1 Liver Cancer -- 4.4.2 Bladder Cancer -- 4.5 Cancer Screening Programs -- 4.6 Cancer Prevention Programs -- 4.6.1 Anti-Schistosomiasis Campaigns -- 4.6.2 Anti-HCV and HBV Campaigns -- 4.7 Cancer Diagnosis -- 4.7.1 Imaging -- 4.7.2 Molecular Testing -- 4.7.3 Cytogenetics and Genetic Testing -- 4.8 Treatment -- 4.8.1 Medical Oncology -- 4.8.2 Radiation Therapy -- 4.8.3 Surgery -- 4.8.4 Pediatric Oncology -- 4.8.5 Survivorship Track -- 4.8.6 Palliative Care Track -- 4.9 Research and Education -- 4.10 Cost-Effective Cancer Care -- 4.11 Challenges and Advantages -- 4.12 The Future of Cancer Care in Egypt -- 4.13 Conclusion -- References -- Chapter 5: General Oncology Care in Iraq -- 5.1 Iraq Demographics -- 5.2 Cancer Statistics in Iraq -- 5.3 Healthcare System in Iraq -- 5.4 Oncology Care in Iraq -- 5.5 Cancer Risk Factors -- 5.6 Cancer Screening Programs -- 5.7 Cancer Prevention Programs -- 5.8 Cancer Diagnosis -- 5.8.1 Imaging -- 5.8.2 Laboratory -- 5.8.3 Cytogenetic and Molecular Genetics -- 5.9 Treatment -- 5.9.1 Medical and Radiation Oncology -- 5.9.2 Medical Oncology -- 5.9.2.1 Hematopoietic Stem Cell Transplantation -- 5.9.3 Radiation Therapy -- 5.9.4 Surgery.

7.10 The Future of Cancer Care in Kuwait -- 7.11 Conclusion -- References -- Chapter 8: General Oncology Care in Lebanon -- 8.1 Lebanon Demography -- 8.2 Cancer Statistics in Lebanon -- 8.3 Healthcare System in Lebanon -- 8.4 Oncology Care in Lebanon -- 8.5 Cancer Risk Factors -- 8.6 Cancer Screening Programs -- 8.7 Cancer Prevention Programs -- 8.8 Cancer Diagnosis -- 8.8.1 Imaging -- 8.8.2 Laboratory -- 8.8.3 Cytogenetics and Medical Genetics -- 8.8.4 Molecular Diagnostics -- 8.9 Treatment -- 8.9.1 Medical Oncology -- 8.9.2 Radiation Therapy -- 8.9.3 Surgery -- 8.9.4 Pediatric Oncology -- 8.9.5 Survivorship Track -- 8.9.6 Palliative Care Track -- 8.10 Research and Education -- 8.11 Cost-Effective Cancer Care -- 8.12 Challenges and Advantages -- 8.12.1 Facilities Providing Cancer Care -- 8.12.2 Treatment Availability -- 8.13 The Future of Cancer Care in Lebanon -- 8.14 Conclusion -- References -- Chapter 9: General Oncology Care in Libya -- 9.1 Libya Demographics -- 9.2 Cancer Statistics in Libya -- 9.3 Healthcare System in Libya -- 9.4 Oncology Care in Libya -- 9.5 Cancer Risk Factors -- 9.6 Cancer Screening Programs -- 9.7 Cancer Prevention Programs -- 9.8 Cancer Diagnosis -- 9.8.1 Imaging -- 9.8.2 Laboratory -- 9.9 Treatment -- 9.9.1 Medical Oncology -- 9.9.1.1 Advanced Treatments -- 9.9.1.2 Bone Marrow Transplantation -- 9.9.2 Radiation Therapy -- 9.9.3 Surgery -- 9.9.4 Pediatric Oncology -- 9.9.5 Survivorship Track -- 9.9.6 Palliative Care Track -- 9.10 Research and Education -- 9.10.1 Research -- 9.10.2 Education and Training -- 9.11 Cost-Effective Cancer Care -- 9.12 Challenges and Advantages -- 9.12.1 Medical Tourism in Libya -- 9.13 The Future of Cancer Care in Libya -- 9.14 Conclusion -- References -- Chapter 10: General Oncology Care in Mauritania -- 10.1 Mauritania Demographics -- 10.2 Cancer Statistics in Mauritania.

10.3 Healthcare System in Mauritania -- 10.4 Oncology Care in Mauritania -- 10.5 Cancer Risk Factors -- 10.6 Cancer Screening Programs -- 10.7 Cancer Prevention Programs -- 10.8 Cancer Diagnosis -- 10.9 Treatment -- 10.9.1 Medical Oncology -- 10.9.2 Radiation Therapy -- 10.9.3 Surgery -- 10.9.4 Pediatric Oncology -- 10.9.5 Survivorship Track -- 10.9.6 Palliative Care Track -- 10.10 Research and Education -- 10.11 Cost-Effective Cancer Care -- 10.12 Challenges and Advantages -- 10.13 The Future of Cancer Care in Mauritania -- 10.14 Conclusion -- References -- Chapter 11: General Oncology Care in Morocco -- 11.1 Morocco Demographics -- 11.2 Cancer Statistics in Morocco -- 11.3 Cancer Risk Factors -- 11.3.1 Tobacco -- 11.3.2 Alcohol -- 11.3.3 Obesity -- 11.3.4 Other Risk Factors -- 11.4 Cancer Screening Programs -- 11.5 Cancer Prevention Programs -- 11.6 Cancer Diagnosis -- 11.7 Treatment -- 11.7.1 Medical Oncology -- 11.7.2 Radiation Therapy -- 11.7.3 Surgery -- 11.7.4 Pediatric Oncology -- 11.7.5 Survivorship Track -- 11.7.6 Palliative Care Track -- 11.8 Research and Education -- 11.8.1 Research -- 11.8.2 Education -- 11.9 Cost-Effective Cancer Care -- 11.10 Challenges and Advantages -- 11.11 The Future of Cancer Care in Morocco -- 11.11.1 Quality Improvement -- 11.11.2 Information Systems -- 11.12 Conclusion -- References -- Chapter 12: General Oncology Care in Oman -- 12.1 Oman Demographics -- 12.2 Cancer Statistics in Oman -- 12.3 Healthcare System in Oman -- 12.4 Oncology Care in Oman -- 12.4.1 Access to Cancer Care services -- 12.4.2 Multi-sectoral Efforts to Prevent and Control Cancer -- 12.4.3 National Oncology Center: The Royal Hospital -- 12.4.4 Other Cancer Centers -- 12.4.5 National Cancer Registry -- 12.4.6 Community Obligations -- 12.4.7 The Cancer Care Plan -- 12.5 Cancer Risk Factors -- 12.6 Cancer Screening Programs.

12.7 Cancer Prevention Programs.

3.8.2 Radiation Therapy -- 3.8.3 Surgery -- 3.8.4 Pediatric Oncology -- 3.8.5 Survivorship Track -- 3.8.6 Palliative Care Track -- 3.9 Research and Education -- 3.9.1 National Tumor Board (NTB) -- 3.10 Cost-Effective Cancer Care -- 3.11 Challenges and Advantages -- 3.12 The Future of Cancer Care in Bahrain -- 3.13 Conclusion -- References -- Chapter 4: General Oncology Care in Egypt -- 4.1 Egypt Demographics -- 4.1.1 Population -- 4.1.2 Regions -- 4.1.3 Economy -- 4.1.4 Government -- 4.1.5 Life Expectancy -- 4.2 Cancer Statistics in Egypt -- 4.3 Oncology Care in Egypt -- 4.3.1 Liver Cancer -- 4.3.2 Breast Cancer -- 4.3.3 Bladder Cancer -- 4.4 Cancer Risk Factors -- 4.4.1 Liver Cancer -- 4.4.2 Bladder Cancer -- 4.5 Cancer Screening Programs -- 4.6 Cancer Prevention Programs -- 4.6.1 Anti-Schistosomiasis Campaigns -- 4.6.2 Anti-HCV and HBV Campaigns -- 4.7 Cancer Diagnosis -- 4.7.1 Imaging -- 4.7.2 Molecular Testing -- 4.7.3 Cytogenetics and Genetic Testing -- 4.8 Treatment -- 4.8.1 Medical Oncology -- 4.8.2 Radiation Therapy -- 4.8.3 Surgery -- 4.8.4 Pediatric Oncology -- 4.8.5 Survivorship Track -- 4.8.6 Palliative Care Track -- 4.9 Research and Education -- 4.10 Cost-Effective Cancer Care -- 4.11 Challenges and Advantages -- 4.12 The Future of Cancer Care in Egypt -- 4.13 Conclusion -- References -- Chapter 5: General Oncology Care in Iraq -- 5.1 Iraq Demographics -- 5.2 Cancer Statistics in Iraq -- 5.3 Healthcare System in Iraq -- 5.4 Oncology Care in Iraq -- 5.5 Cancer Risk Factors -- 5.6 Cancer Screening Programs -- 5.7 Cancer Prevention Programs -- 5.8 Cancer Diagnosis -- 5.8.1 Imaging -- 5.8.2 Laboratory -- 5.8.3 Cytogenetic and Molecular Genetics -- 5.9 Treatment -- 5.9.1 Medical and Radiation Oncology -- 5.9.2 Medical Oncology -- 5.9.2.1 Hematopoietic Stem Cell Transplantation -- 5.9.3 Radiation Therapy -- 5.9.4 Surgery.

5.9.5 Pediatric Oncology -- 5.9.6 Survivorship Track -- 5.9.7 Palliative Care Track -- 5.10 Research and Education -- 5.10.1 Research -- 5.10.1.1 The Iraqi Regional Comparative Breast Cancer Research Project -- 5.10.2 Education and Training -- 5.10.2.1 Local Education and Training -- 5.10.2.2 International Collaborations and Country Program Frameworks -- 5.11 Cost-Effective Cancer Care -- 5.12 Challenges and Advantages -- 5.13 The Future of Cancer Care in Iraq -- 5.14 Conclusion -- References -- Chapter 6: General Oncology Care in Jordan -- 6.1 Jordan Demographics -- 6.2 Cancer Statistics in Jordan -- 6.3 Healthcare System in Jordan -- 6.4 Oncology Care in Jordan -- 6.5 Cancer Risk Factors -- 6.6 Cancer Screening Programs -- 6.7 Cancer Prevention Programs -- 6.8 Cancer Diagnosis -- 6.9 Treatment -- 6.9.1 Medical Oncology -- 6.9.2 Radiation Therapy -- 6.9.3 Surgery -- 6.9.4 Pediatric Oncology -- 6.9.5 Survivorship Track -- 6.9.6 Palliative Care Track -- 6.10 Research and Education -- 6.11 Cost-Effective Cancer Care -- 6.12 Challenges and Advantages -- 6.12.1 Medical Tourism in Jordan -- 6.13 The Future of Cancer Care in Jordan -- 6.14 Conclusion -- References -- Chapter 7: General Oncology Care in Kuwait -- 7.1 Kuwait Demographics -- 7.2 Cancer Statistics in Kuwait -- 7.3 Cancer Risk Factors -- 7.3.1 Part 1: Ubiquitous Risk Factors: Where Does Kuwait Stand? -- 7.3.2 Part 2: Other Kuwait-Specific Risk Factors -- 7.4 Cancer Screening Programs -- 7.5 Cancer Prevention Programs -- 7.6 Cancer Diagnosis -- 7.6.1 Specialized Laboratory Services -- 7.7 Treatment -- 7.7.1 Medical Oncology -- 7.7.1.1 Malignant Hematology and Bone Marrow Transplantation (BMT) -- 7.7.2 Radiation Therapy -- 7.7.3 Surgery -- 7.7.4 Pediatric Oncology -- 7.7.5 Survivorship Track -- 7.7.6 Palliative Care Track -- 7.8 Research and Education -- 7.9 Challenges and Advantages.

7.10 The Future of Cancer Care in Kuwait -- 7.11 Conclusion -- References -- Chapter 8: General Oncology Care in Lebanon -- 8.1 Lebanon Demography -- 8.2 Cancer Statistics in Lebanon -- 8.3 Healthcare System in Lebanon -- 8.4 Oncology Care in Lebanon -- 8.5 Cancer Risk Factors -- 8.6 Cancer Screening Programs -- 8.7 Cancer Prevention Programs -- 8.8 Cancer Diagnosis -- 8.8.1 Imaging -- 8.8.2 Laboratory -- 8.8.3 Cytogenetics and Medical Genetics -- 8.8.4 Molecular Diagnostics -- 8.9 Treatment -- 8.9.1 Medical Oncology -- 8.9.2 Radiation Therapy -- 8.9.3 Surgery -- 8.9.4 Pediatric Oncology -- 8.9.5 Survivorship Track -- 8.9.6 Palliative Care Track -- 8.10 Research and Education -- 8.11 Cost-Effective Cancer Care -- 8.12 Challenges and Advantages -- 8.12.1 Facilities Providing Cancer Care -- 8.12.2 Treatment Availability -- 8.13 The Future of Cancer Care in Lebanon -- 8.14 Conclusion -- References -- Chapter 9: General Oncology Care in Libya -- 9.1 Libya Demographics -- 9.2 Cancer Statistics in Libya -- 9.3 Healthcare System in Libya -- 9.4 Oncology Care in Libya -- 9.5 Cancer Risk Factors -- 9.6 Cancer Screening Programs -- 9.7 Cancer Prevention Programs -- 9.8 Cancer Diagnosis -- 9.8.1 Imaging -- 9.8.2 Laboratory -- 9.9 Treatment -- 9.9.1 Medical Oncology -- 9.9.1.1 Advanced Treatments -- 9.9.1.2 Bone Marrow Transplantation -- 9.9.2 Radiation Therapy -- 9.9.3 Surgery -- 9.9.4 Pediatric Oncology -- 9.9.5 Survivorship Track -- 9.9.6 Palliative Care Track -- 9.10 Research and Education -- 9.10.1 Research -- 9.10.2 Education and Training -- 9.11 Cost-Effective Cancer Care -- 9.12 Challenges and Advantages -- 9.12.1 Medical Tourism in Libya -- 9.13 The Future of Cancer Care in Libya -- 9.14 Conclusion -- References -- Chapter 10: General Oncology Care in Mauritania -- 10.1 Mauritania Demographics -- 10.2 Cancer Statistics in Mauritania.

001896839

express

(Au-PeEL)EBL6927300

(MiAaPQ)EBC6927300

(OCoLC)1306214451